GPS Wealth Strategies Group’s Precision BioSciences DTIL Stock Holding History

GPS Wealth Strategies Group’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1	Closed	-$9	–	1394
2024 Q3	$9	Hold	1	–	–	﹤0.01%	1391
2024 Q2	$10	Hold	1	–	–	﹤0.01%	1353
2024 Q1	$14	Buy	+1	New	+$12	﹤0.01%	1244

Other funds holding DTIL

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

MSAM

Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

GPS Wealth Strategies Group's DTIL Position: Q4 2024 in Review

GPS Wealth Strategies Group sold out of Precision BioSciences (DTIL) in Q4 2024, closing a stake of 1 share — an estimated $9 sold.

GPS Wealth Strategies Group first reported a position in DTIL in Q1 2024 and held it in 3 quarters. The position peaked at $14 in Q1 2024. 55 funds tracked by Wall St. Rank hold DTIL as of Q4 2024.

GPS Wealth Strategies Group reported no remaining Precision BioSciences position as of Q4 2024 after selling out during the quarter.
GPS Wealth Strategies Group sold 1 Precision BioSciences share in Q4 2024, an estimated $9.
GPS Wealth Strategies Group first reported a position in Precision BioSciences in Q1 2024 and held it in 3 quarters.
GPS Wealth Strategies Group's Precision BioSciences position peaked at $14 in Q1 2024.
55 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2024.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2024, filed 24 Jan 2025.